Pfizer profit soars in first quarter, revises 2022 forecast
COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's firstquarter expectations, as the drugmaker's profit grew 61%. |!| Miles City
COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street's firstquarter expectations, as the drugmaker's profit grew 61%. |!| Miles City